It is not at all, not in the least. We wanted to make sure that we were supporting developing countries, and at the same time, the way in which the COVAX facility worked was that it had two pillars, the advance market commitment for low-income countries and the facility for self-financing countries. We invested $220 million in both pillars. We just accepted the AstraZeneca doses that were dedicated to Canada according to equitable allocation mechanisms. In fact, other developed countries like New Zealand are also accepting doses as well.
On February 5th, 2021. See this statement in context.